Expanded Program On Immunization

Expanded Program on Immunization

Background and Definition

Expanded Program on Immunization (EPI), established in 1987, aimes at guaranteeing the right of every child in Lebanon, regardless of social status or parent's education level, on immunization and protection from diseases that have available effective and safe vaccines. In order to ensure that, the Ministry of Public Health guarantees the provision of vaccines in 700 health care centers, public and social, in collaboration with the private sector and with the conitnuous awareness of care givers about the importance of immunization. The program provides further special attention to chidlren residing in remote and underprivileged areas through quality outreach activities.

EPI ِAims at:

Elevating routine vaccination coverage per district to above 95%.
Preserving Lebanon as polio-free, considering the continuous influx of Syrian refugees and in preparation to the eradication of polio in the region and worldwide.
Eradicating Measles and Rubella by the end of year 2018.

EPI Activities:

Continuous training and capacity building throughout the year for health care workers on routine vaccination management and implementation in all districs.
Continuous work to keep Lebanon certified polio-free
Implementation of the RED STRATEGY to reach every child, which includes:
1. Data on the immunization coverage for children under one year of age
2. Data on immunization coverage in Lebanon
3. Identification of the number of drop-outs and planning to ensure their vaccination per district accordingly
Celebrating World Immunization Week and planning awareness sessions over Lebanon about routine vaccination
Conducting National and Mop-Up Immunization campaigns annually, including vaccination against Measles, Rubella, and Mumps
Conducting regular visits by the self-assessment team to follow on the quality of vaccination delivery service
Continuous collaboration with UNICEFand WHO to follow-up on updates related to immunization worldwide and ensuring implementation in Lebanon considering national and international commitments
Continuous collaboration with the private sector (General Practictioners and Pediatricians) to ensure vaccination for all children in Lebanon, particularly during immunization campaigns and routine immunization.

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C03DA01	ALDACTONE	B	Spironolactone - 100mg	100mg	Tablet	458,250 L.L
C03DA01	ALDACTONE	B	Spironolactone - 25mg	25mg	Tablet	237,860 L.L
C03CA01	APO-FUROSEMIDE	G	Furosemide - 40mg	40mg	Tablet, scored	862,747 L.L
C03BA11	ADEX	G	Indapamide - 1.5mg	1.5mg	Tablet, prolonged release	296,989 L.L
C02LA51	ADELPHAN ESIDREX	B	Reserpine - 0.1mg, Hydrochlorothiazide - 10mg, Dihydralazine - 10mg		Tablet	371,157 L.L
C02AB02	ALDOMET	B	Methyldopa - 250mg	250mg	Tablet, coated	644,400 L.L
C02AB02	ALDOMET	B	Methyldopa - 500mg	500mg	Tablet, coated	856,708 L.L
C01CA24	ADRENALINE 1 MG I.V.	G	Adrenaline - 1mg/ml	1mg/ml	Injectable solution	2,239,738 L.L
C01CA24	ADRENALINE RENAUDIN	G	Epinephrine (tartrate) - 1mg/ml	1mg	Injectable solution	444,812 L.L
C01CA24	ADRENALINE SALF	G	Adrenaline - 1mg/ml	1mg/ml	Injectable solution	220,390 L.L
C01CA24	ADRENALINE AGUETTANT	G	Adrenaline - 0.1mg/ml	0.1mg/ml	Injectable solution	13,990,891 L.L
C01BD01	AMIODARONE BIOGARAN	G	Amiodarone (HCl) - 200mg	200mg	Tablet	345,368 L.L
B05XA31	ADDAVEN	G	Chromic chloride 6H2O - 53mcg/10ml, Copper chloride dihydrate - 1.02mg/10ml, Ferric Chloride hexahydrate - 5.40mg/10ml, Manganese chloride 4H2O - 198mcg/10ml, Potassium iodide - 166mcg/10ml, Sodium fluoride - 2.10mg/10ml		Injectable concentrate for solution	4,065,124 L.L
B05CX01	ALDEX	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	174,062 L.L
B05CX01	ALDEX	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	174,062 L.L
B05CX01	ALDEX	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	170,630 L.L
B05CX01	ALDEX	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	182,720 L.L
B05CX01	ALDEX	G	Dextrose, H2O - 5g/100ml	5g/100ml	Injectable solution	205,933 L.L
B05BA01	AMINOVEN 10%	B	Glacial Acetic Acid 99% - 5.297g/l, L-Proline - 15.0g/l, L-Alanine - 15.0g/l, Glycine - 14.0g/l, L-Histidine - 3.00g/l, L-Arginine - 12.0g/l, L-Valine - 6.20g/l, L-Tryptophan - 2.00g/l, L-Threonine - 4.40g/l, L-Phenylalanine - 5.10g/l, L-Methionine - 4.30g/l, L-Lysine (monoacetate) - 6.60g/l, L-Leucine - 7.40g/l, L-Isoleucine - 5.00g/l		Injectable solution	951,440 L.L
B05BA01	AMINOVEN INFANT	B	L-Leucine - 13g/l, L-Isoleucine - 8g/l, L-Lysine Acetate - 12g/l, L-Methionine - 3.12g/l, L-Phenylalanine - 3.75g/l, L-Threonine - 4.40g/l, L-Tryptophan - 2.01g/l, L-Valine - 9g/l, Arginine - 7.5g/l, L-Histidine - 4.76g/l, Glycine - 4.15g/l, L-Taurine - 0.40g/l, L-Serine - 7.67g/l, L-Alanine - 9.3g/l, L-Proline - 9.71g/l, N-Acetyl-L-Tyrosine - 5.176g/l, N-Acetyl-L-Cysteine - 0.70g/l, L-Malic Acid - 2.62g/l	10%	Injectable solution	880,217 L.L
B05BA01	AMINOPLASMAL B. BRAUN	B	Amino acids - 10%	10%	Injectable solution	1,036,103 L.L
B05AA01	ALBUKEY	BioHuman	Albumin human - 20%	20%	Injectable solution	4,863,366 L.L
B05AA01	ALBUREL HUMAN ALBUMIN BP	BioHuman	Albumin human - 20%	20%	Injectable solution	3,240,004 L.L
B05AA01	ALBUREL HUMAN ALBUMIN BP	BioHuman	Albumin human - 20%	20%	Injectable solution	6,353,687 L.L
B05AA01	ALBUTEIN	BioHuman	Albumin human - 20%	20%	Injectable solution	7,154,928 L.L
B05AA01	ALBUTEIN	BioHuman	Albumin human - 20%		Injectable solution	4,031,528 L.L
B05AA01	ALBUREL HUMAN ALBUMIN BP	BioHuman	Albumin human - 20%	20%	Injectable solution	L.L
B03XA01	ALPEEN	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 10,000IU	10000IU	Injectable solution	4,036,903 L.L
B03XA01	ALPEEN	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 10,000IU	10,000IU	Injectable solution	10,661,285 L.L
B03XA01	ALPEEN	BioTech	Erythropoietin recombinant human (Epoetin alfa) - 4000IU	4000IU	Injectable solution	8,728,144 L.L

...